Frequently Asked Questions
Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
1. PT / INR
The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.
Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.
Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.
Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.
Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.
2. What is minimally invasive endocrine surgery?
Minimally invasive endocrine surgery involves using small incisions and advanced tools to treat disorders of the thyroid, parathyroid, or adrenal glands with reduced recovery time and scarring.
3. DENGUE IGM
A positive result indicates recent or current infection with the Dengue virus.
No, additional tests, such as Dengue NS1 antigen test or PCR, may be required to identify the specific serotype.
No, the Dengue IgM test is designed to detect recent or current infections during the acute phase.
Dengue IgM antibodies are typically detectable in the bloodstream for up to 3 months after infection.
A negative result suggests no detectable Dengue IgM antibodies. If symptoms persist or there is recent exposure, consult a healthcare provider for further evaluation.